相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer
Kelli M. Luginbuhl et al.
NATURE BIOMEDICAL ENGINEERING (2017)
Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411
Sif Holmboe et al.
PLOS ONE (2017)
Identification of a peptide-peptide binding motif in the coating of nab-paclitaxel nanoparticles with clinical antibodies: bevacizumab, rituximab, and trastuzumab
John T. Butterfield et al.
SCIENTIFIC REPORTS (2017)
Efficient VEGF targeting delivery of DOX using Bevacizumab conjugated SiO2@LDH for anti-neuroblastoma therapy
Rongrong Zhu et al.
ACTA BIOMATERIALIA (2017)
New Life for Immunotoxin Cancer Therapy
Raffit Hassan et al.
CLINICAL CANCER RESEARCH (2016)
A Modular Method for the High-Yield Synthesis of Site-Specific Protein-Polymer Therapeutics
Yan Pang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Dacomitinib versus erlotinib in patients with EGFR-mutated advanced nonsmall-cell lung cancer (NSCLC): pooled subset analyses from two randomized trials
S. S. Ramalingam et al.
ANNALS OF ONCOLOGY (2016)
PEGylated Albumin-Based Polyion Complex Micelles for Protein Delivery
Yanyan Jiang et al.
BIOMACROMOLECULES (2016)
A Supramolecular Approach toward Bioinspired PAMAM-Dendronized Fusion Toxins
Seah Ling Kuan et al.
MACROMOLECULAR BIOSCIENCE (2016)
Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model
Joao Conde et al.
NATURE MATERIALS (2016)
Modulation of RhoA GTPase Activity Sensitizes Human Cervix Carcinoma Cells to γ-Radiation by Attenuating DNA Repair Pathways
Juliana H. Osaki et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Water-soluble allyl sulfones for dual site-specific labelling of proteins and cyclic peptides
Tao Wang et al.
CHEMICAL SCIENCE (2016)
Approaches of targeting Rho GTPases in cancer drug discovery
Yuan Lin et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
Using combination therapy to thwart drug resistance
Jessica A. Hill et al.
FUTURE MICROBIOLOGY (2015)
Clostridial C3 toxins target monocytes/macrophages and modulate their functions
Holger Barth et al.
FRONTIERS IN IMMUNOLOGY (2015)
Therapeutic Strategies for Neuroendocrine Liver Metastases
Andrea Frilling et al.
CANCER (2015)
A Disulfide Intercalator Toolbox for the Site-Directed Modification of Polypeptides
Tao Wang et al.
CHEMISTRY-A EUROPEAN JOURNAL (2015)
The chick embryo chorioallantoic membrane as a model for tumor biology
Domenico Ribatti
EXPERIMENTAL CELL RESEARCH (2014)
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
Eric Pujade-Lauraine et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Antibody-drug gold nanoantennas with Raman spectroscopic fingerprints for in vivo tumour theranostics
Joao Conde et al.
JOURNAL OF CONTROLLED RELEASE (2014)
The effect of albumin fusion structure on the production and bioactivity of the somatostatin-28 fusion protein in Pichia pastoris
Yuedi Ding et al.
JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY (2014)
Dendronized Albumin Core-Shell Transporters with High Drug Loading Capacity
Seah Ling Kuan et al.
BIOMACROMOLECULES (2013)
pH Responsive Janus-like Supramolecular Fusion Proteins for Functional Protein Delivery
Seah Ling Kuan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Multivalency of Non-Peptide Integrin αVβ3 Antagonist Slows Tumor Growth
Yoo-Shin Kim et al.
MOLECULAR PHARMACEUTICS (2013)
C3 Rho-Inhibitor for Targeted Pharmacological Manipulation of Osteoclast-Like Cells
Andrea Tautzenberger et al.
PLOS ONE (2013)
Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines
M. Tontini et al.
VACCINE (2013)
RHOA-FAK Is a Required Signaling Axis for the Maintenance of KRAS-Driven Lung Adenocarcinomas
Georgia Konstantinidou et al.
CANCER DISCOVERY (2013)
Beyond Bevacizumab: Antiangiogenic Agents
Shane Rogosin et al.
CLINICAL LUNG CANCER (2012)
Stratified medicine for cancer therapy
Emily C. Shaw et al.
DRUG DISCOVERY TODAY (2012)
DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo
Ji-Liang Li et al.
CANCER RESEARCH (2011)
Somatostatin Receptor-Targeted Anti-Cancer Therapy
Li-Chun Sun et al.
CURRENT DRUG DELIVERY (2011)
Therapeutic Use of Avidin Is Not Hampered by Antiavidin Antibodies in Humans
Fiorella Petronzelli et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2010)
Selective and specific internalization of clostridial C3 ADP-ribosyltransferases into macrophages and monocytes
Joerg Fahrer et al.
CELLULAR MICROBIOLOGY (2010)
Delivery of Therapeutic Proteins
Dipak S. Pisal et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Bevacizumab Increases Risk for Severe Proteinuria in Cancer Patients
Shenhong Wu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Tirucallic Acids Are Novel Pleckstrin Homology Domain-Dependent Akt Inhibitors Inducing Apoptosis in Prostate Cancer Cells
Aydee C. Estrada et al.
MOLECULAR PHARMACOLOGY (2010)
Janus-like Protein Cages. Spatially Controlled Dual-Functional Surface Modifications of Protein Cages
Sebyung Kang et al.
NANO LETTERS (2009)
PEGylation of cyanovirin-N, an entry inhibitor of HIV
H. Zappe et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design
Sergey M. Deyev et al.
BIOESSAYS (2008)
Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo
Meike Vogler et al.
CANCER RESEARCH (2008)
Chick Chorioallantoic Membrane as an In Situ Biological Membrane for Pharmaceutical Formulation Development: A Review
Constance L. L. Saw et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2008)
Optimizing denileukin diftitox (Ontak®) therapy
Madeleine Duvic et al.
FUTURE ONCOLOGY (2008)
Activation of nuclear factor-κB pathway by Simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells
Chiara Riganti et al.
MOLECULAR PHARMACOLOGY (2008)
Development of a cell transducible RhoA inhibitor TAT-C3 transferase and its encapsulation in biocompatible microspheres to promote survival and enhance regeneration of severed neurons
Elaine Y. M. Tan et al.
PHARMACEUTICAL RESEARCH (2007)
Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models
Federica Pisati et al.
CANCER RESEARCH (2007)
C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins
Martin Vogelsgesang et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2007)
Increasing chemotherapy in small-cell lung cancer: From dose intensity and density to megadoses
Gino Crivellari et al.
ONCOLOGIST (2007)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Site-specific PEGylation of native disulfide bonds in therapeutic proteins
Sunil Shaunak et al.
NATURE CHEMICAL BIOLOGY (2006)
Inhibition of IκB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo
T Syrovets et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo
JY Pillé et al.
MOLECULAR THERAPY (2005)
Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro
GPV Amerongen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Growing vascular endothelial cells express somatostatin subtype 2 receptors
JC Watson et al.
BRITISH JOURNAL OF CANCER (2001)
Somatostatin, its receptors and analogs, in lung cancer
KJ O'Byrne et al.
CHEMOTHERAPY (2001)
The suppression of small GTPase Rho signal transduction pathway inhibits angiogenesis in vitro and in vivo
S Uchida et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)